Konstantin Adamsky

This inventor holds 7 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Regenera Pharma Ltd.. Active years: 2019-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Konstantin Adamsky. Retrieved from https://idiyas.com/inventor/konstantin-adamsky

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 1)

% Patents Active = 28.6

EPO Patents = 1 (Patent Applications = 5)

Average Co-Inventor Count = 3.5

ph-index = 1

Company Filing History:

7 out of 17

Regenera Pharma Ltd.

patents

Years Active: 2019-2021

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11207333 - Compositions comprising triterpenoids and uses thereof for treating optic neuropathy (2021-12-28),

2. 11173164 - Compositions comprising triterpenoids (2021-11-16),

3. 11083736 - Compositions comprising triterpenoids (2021-08-10),

4. 11000562 - Use of isolated fractions of mastic gum for treating optic neuropathy (2021-05-11),

5. 10751347 - Compositions comprising acidic extracts of mastic gum and uses thereof for treating optic neuropathy (2020-08-25),

6. 10588911 - Compositions comprising triterpenoids (2020-03-17),

7. 10285996 - Compositions comprising triterpenoids (2019-05-14),

Title: The Innovative Contributions of Konstantin Adamsky

Introduction

Konstantin Adamsky is a notable inventor based in Gedera, Israel. He has made significant contributions to the field of medical science, particularly in the development of compositions for treating various neurological conditions. With a total of seven patents to his name, Adamsky's work is recognized for its potential impact on healthcare.

Latest Patents

Among his latest patents, Adamsky has developed compositions comprising triterpenoids aimed at treating optic neuropathy. This invention focuses on formulations that include at least one triterpenoic acid and one neutral triterpenoid, showcasing their therapeutic potential for optic neuropathy conditions. Additionally, he has created compositions for treating Alzheimer's disease, Parkinson's disease, and vascular dementia, further emphasizing the versatility of triterpenoids in addressing critical health issues.

Career Highlights

Adamsky's career is marked by his dedication to innovation in the pharmaceutical field. His work at Regenera Pharma Ltd. has positioned him as a key player in the development of new treatments that leverage the properties of triterpenoids. His research not only contributes to scientific knowledge but also aims to improve patient outcomes in neurodegenerative diseases.

Collaborations

Throughout his career, Adamsky has collaborated with esteemed colleagues such as Zadik Hazan and Andre C B Lucassen. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking advancements in medical treatments.

Conclusion

Konstantin Adamsky's contributions to the field of medicine through his innovative patents and collaborative efforts highlight his commitment to improving healthcare. His work continues to pave the way for new therapeutic options for patients suffering from neurological conditions.

Profile summary based on public USPTO records.